AZD0530, AN INHIBITOR OF SRC KINASES, IN PLATINUM-PRETREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A TRIAL OF THE PMH PHASE II CONSORTIUM

被引：0
|
作者：
Laurie, Scott A. [1 ]
Goss, Glenwood D. [1 ]
Shepherd, Frances A. [2 ]
Reaume, Neil [1 ]
Nicholas, Garth [1 ]
Philip, Lindsay [2 ]
Wang, Lisa [2 ]
Oza, Amit [2 ]
Hirsh, Vera [3 ]
Wright, James
Leighl, Natasha [2 ]
机构：
[1] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada
[2] Princess Margaret Hosp, Toronto, ON, Canada
[3] Mcgill Univ Hlth Ctr, Dept Oncol, Montreal, PQ, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
src kinase inhibitor; non-small cell; Phase II;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1262 / S1262
页数：1
相关论文
共 50 条
  • [1] A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium
    Mackay, Helen J.
    Au, Heather J.
    McWhirter, Elaine
    Alcindor, Thierry
    Jarvi, Andrea
    MacAlpine, Katrina
    Wang, Lisa
    Wright, John J.
    Oza, Amit M.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1158 - 1163
  • [2] A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium
    Helen J. Mackay
    Heather J. Au
    Elaine McWhirter
    Thierry Alcindor
    Andrea Jarvi
    Katrina MacAlpine
    Lisa Wang
    John J. Wright
    Amit M. Oza
    Investigational New Drugs, 2012, 30 : 1158 - 1163
  • [3] A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer
    Renouf, Daniel J.
    Moore, Malcolm J.
    Hedley, David
    Gill, Sharlene
    Jonker, Derek
    Chen, Eric
    Walde, David
    Goel, Rakesh
    Southwood, Bernadette
    Gauthier, Isabelle
    Walsh, Wendy
    McIntosh, Lynn
    Seymour, Lesley
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 779 - 786
  • [4] A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer
    Daniel J. Renouf
    Malcolm J. Moore
    David Hedley
    Sharlene Gill
    Derek Jonker
    Eric Chen
    David Walde
    Rakesh Goel
    Bernadette Southwood
    Isabelle Gauthier
    Wendy Walsh
    Lynn McIntosh
    Lesley Seymour
    Investigational New Drugs, 2012, 30 : 779 - 786
  • [5] A Phase II Trial of Saracatinib, an Inhibitor of src Kinases, in Previously-Treated Advanced Non-Small-Cell Lung Cancer: The Princess Margaret Hospital Phase II Consortium
    Laurie, Scott A.
    Goss, Glenwood D.
    Shepherd, Frances A.
    Reaume, M. Neil
    Nicholas, Garth
    Philip, Lindsay
    Wang, Lisa
    Schwock, Joerg
    Hirsh, Vera
    Oza, Amit
    Tsao, Ming-Sound
    Wright, John J.
    Leighl, Natasha B.
    CLINICAL LUNG CANCER, 2014, 15 (01) : 52 - 57
  • [6] PHASE II DRUG DEVELOPMENT IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Lara, Primo
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S437 - S437
  • [7] Phase II study of mitonafide in non-small cell lung cancer (NSCLC)
    Casado, A
    Rosell, R
    GarciaGomez, R
    DiazRubio, E
    PerezManga, G
    Font, A
    Benavides, A
    Martin, M
    INVESTIGATIONAL NEW DRUGS, 1996, 14 (04) : 415 - 417
  • [8] Activity of gemcitabine and carboplatin in advanced non-small cell lung cancer: a phase II trial
    Masotti, A
    Zannini, G
    Gentile, A
    Morandini, G
    LUNG CANCER, 2002, 36 (01) : 99 - 103
  • [9] Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): A multicenter phase II study
    Kakolyris, Stylianos
    Ziras, Nikolaos
    Vamvakas, Lambros
    Varthalitis, John
    Papakotoulas, Pavlos
    Syrigos, Kostas
    Vardakis, Nikolaos
    Kalykaki, Antonia
    Amarantidis, Kiriakos
    Georgoulias, Vassilis
    LUNG CANCER, 2006, 54 (03) : 347 - 352
  • [10] Phase II Study of Erlotinib in Japanese Patients with Advanced Non-small Cell Lung Cancer
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    Nukiwa, Toshihiro
    Mori, Kiyoshi
    Tsuboi, Masahiro
    Horai, Takeshi
    Masuda, Noriyuki
    Eguchi, Kenji
    Mitsudomi, Tetsuya
    Yokota, Soichiro
    Segawa, Yoshihiko
    Ichinose, Yukito
    Fukuoka, Masahiro
    Saijo, Nagahiro
    ANTICANCER RESEARCH, 2010, 30 (02) : 557 - 563
12345